Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Joly

Showing results (11-20 of 226) with videos related to

Pageof 23
Sort By:
Immunotherapy|October 25, 2017
Rituximab in pemphigusVivien Hebert, Pascal Joly
La Revue Du Praticien|May 30, 2006
[Pruritus (with treatment)]Pascal Joly, Hélène Lapeyre
Current Problems in Dermatology|November 14, 2017
Bullous DiseasesCaroline Corbaux, Pascal Joly
Clinical and Experimental Dermatology|July 19, 2023
Major improvement of very severe alopecia areata in patients treated with the combination of baricitinib and low doses of corticosteroids: an eight-case seriesVivien Hébert, Pascal Joly
The British Journal of Dermatology|June 27, 2026
Comment on 'Incidence and Mortality of Mucous Membrane Pemphigoid in France': reply from authorsBillal Tedbirt, Pascal Joly
La Revue Du Praticien|September 17, 2005
[Bullous pemphigoid]Julie de Quatrebarbes, Pascal Joly
Presse Medicale (Paris, France : 1983)|September 7, 2010
[Pemphigus]Hélène Lapeyre-Liénard, Pascal Joly
The New England Journal of Medicine|April 1, 2008
Case 36-2007: a woman with rash, fever, and hypotensionVincent Descamps, Pascal Joly, Philippe Musette
Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2023
Individual meta-analysis of vital prognostic factors of patients with bullous pemphigoidBillal Tedbirt, Pascal Joly, André Gillibert
Lancet (London, England)|September 10, 2019
PemphigusEnno Schmidt, Michael Kasperkiewicz, Pascal Joly
Pageof 23

Showing results (11-20 of 226) with videos related to

Sort By:
Pageof 23
Immunotherapy|October 25, 2017
Rituximab in pemphigusVivien Hebert, Pascal Joly
La Revue Du Praticien|May 30, 2006
[Pruritus (with treatment)]Pascal Joly, Hélène Lapeyre
Current Problems in Dermatology|November 14, 2017
Bullous DiseasesCaroline Corbaux, Pascal Joly
Clinical and Experimental Dermatology|July 19, 2023
Major improvement of very severe alopecia areata in patients treated with the combination of baricitinib and low doses of corticosteroids: an eight-case seriesVivien Hébert, Pascal Joly
The British Journal of Dermatology|June 27, 2026
Comment on 'Incidence and Mortality of Mucous Membrane Pemphigoid in France': reply from authorsBillal Tedbirt, Pascal Joly
La Revue Du Praticien|September 17, 2005
[Bullous pemphigoid]Julie de Quatrebarbes, Pascal Joly
Presse Medicale (Paris, France : 1983)|September 7, 2010
[Pemphigus]Hélène Lapeyre-Liénard, Pascal Joly
The New England Journal of Medicine|April 1, 2008
Case 36-2007: a woman with rash, fever, and hypotensionVincent Descamps, Pascal Joly, Philippe Musette
Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2023
Individual meta-analysis of vital prognostic factors of patients with bullous pemphigoidBillal Tedbirt, Pascal Joly, André Gillibert
Lancet (London, England)|September 10, 2019
PemphigusEnno Schmidt, Michael Kasperkiewicz, Pascal Joly
Pageof 23